In situ hybridization analysis of invasive breast carcinomas with immunohistochemically negative her-2 status (a national multicenter study) | Zendy

Sıtkı Tuzlalı | Zendy; Ekrem Yavuz | Zendy; Tülay Canda | Zendy; Merih Güray | Zendy; Melin Özgün Geçer | Zendy; Yurdanur Süllü | Zendy; Cem Sezer | Zendy; Dinç Süren | Zendy; Serpil Dızbay Sak | Zendy; Zerrin Calay | Zendy; Şennur İlvan | Zendy; Suzan Zorludemir | Zendy; Melek Ergin | Zendy; Fatma Şeyda Karaveli | Zendy; Elif Peştereli | Zendy; Fatih Özdener | Zendy; Kasım Üstündağ | Zendy

Open Access

In situ hybridization analysis of invasive breast carcinomas with immunohistochemically negative her-2 status (a national multicenter study)

Author(s) -

Sıtkı Tuzlalı,

Ekrem Yavuz,

Tülay Canda,

Merih Güray,

Melin Özgün Geçer,

Yurdanur Süllü,

Cem Sezer,

Dinç Süren,

Serpil Dızbay Sak,

Zerrin Calay,

Şennur İlvan,

Suzan Zorludemir,

Melek Ergin,

Fatma Şeyda Karaveli,

Elif Peştereli,

Fatih Özdener,

Kasım Üstündağ

Publication year - 2014

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2014.01240

Subject(s) - polysomy , immunohistochemistry , breast cancer , medicine , in situ hybridization , gene duplication , pathology , cancer , biology , gene , gene expression , genetics

The aim of this study was to determine the rate of Her-2 gene amplification in breast cancer cases with a previous negative Her-2 result as determined by immunohistochemistry (score 0 or 1).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research